Hikma Pharmaceuticals PLC - Company Secretary Change

London, 15 June 2022 - Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK) (Hikma) announces that Peter Speirs will step down as Company Secretary and Hussein Arkhagha, Chief Counsel, will take on the additional role as Company Secretary effective from 15 June 2022.

-- ENDS --

Enquiries:

Hikma Pharmaceuticals PLC

Susan Ringdal, EVP Strategy and Global Affairs                                                             +44 (0)20 7399 2760

About Hikma

Hikma helps put better health within reach every day for millions of people around the world. For more than 40 years, we've been creating high-quality medicines and making them accessible to the people who need them. Headquartered in the UK, we are a global company with a local presence across the United States (US), the Middle East and North Africa (MENA) and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people's lives. We're committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 8,700 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner, and through our venture capital arm, are helping bring innovative health technologies to people around the world. For more information, please visit: www.hikma.com

(LEI:549300BNS685UXH4JI75)